You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abscopal Effect

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Secondary Malignant Tumor Trial (SBRT + LDRT, SBRT alone)

Not yet recruiting
  • Neoplasms
  • Secondary Malignant Neoplasm
  • SBRT + LDRT
  • SBRT alone
  • (no location specified)
Nov 15, 2022

Tumors, Secondary Malignant Tumor Trial in Seoul (SBRT + LDRT)

Recruiting
  • Neoplasms
  • Secondary Malignant Neoplasm
  • SBRT + LDRT
  • Seoul, Korea, Republic of
  • +1 more
Feb 16, 2023

Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)

Recruiting
  • Thymoma
  • Radiotherapy Combined with GM-CSF
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 2, 2022

Bystander Effect, Abscopal Effect, Unresectable Malignant Solid Tumor Trial in Klagenfurt (SBRT-PATHY (SBRT-based PArtial Tumor

Recruiting
  • Bystander Effect
  • +3 more
  • SBRT-PATHY (SBRT-based PArtial Tumor irradiation targeting HYpoxic segment)
  • Klagenfurt, Kaernten, Austria
    KABEG Klinikum Klagenfurt, Institute for Radiation Oncology
Apr 6, 2022

Non-Small-Cell Lung Cancer Stage IV Trial in Chongqing (Bevacizumab, Toripalimab, SBRT)

Recruiting
  • Non-Small-Cell Lung Cancer Stage IV
  • Chongqing, Chongqing, China
    Xinqiao Hospital of Chongqing
May 13, 2021

Melanoma Trial in France (Nivolumab + Ipilimumab, Combined treatment schema)

Terminated
  • Melanoma
  • Nivolumab + Ipilimumab
  • Combined treatment schema
  • Bordeaux, France
  • +5 more
Dec 3, 2020

Thymic Epithelial Tumor Trial in Shanghai (rhGM-CSF,Peginterferon alfa-b2,radiation)

Not yet recruiting
  • Thymic Epithelial Tumor
  • rhGM-CSF，Peginterferon alfa-b2，radiation
  • Shanghai, Shanghai, China
    Fudan University shanghai cancer center
Aug 16, 2020

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023

Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Head Neck Cancer Trial in France (Systemic treatment +

Withdrawn
  • Metastatic Breast Cancer
  • +2 more
  • Systemic treatment + Stereotactic Body Radio-Therapy (SBRT)
  • Systemic treatment
  • Albi, France
  • +5 more
Jan 28, 2020

Colorectal Cancer, Metastatic Colorectal Cancer, Thymalfasin Trial (Radiation therapy, Thymalfasin)

Withdrawn
  • Colorectal Cancer
  • +2 more
  • (no location specified)
Jun 18, 2019

Metastatic Colorectal Cancer, pMMR, MSS Trial in France (Atezolizumab, Therasphere, XELOX)

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Amiens, France
  • +18 more
Mar 23, 2022

Small Cell Lung Cancer, Radiotherapy, Thymalfasin Trial (Radiotherapy, Thymalfasin)

Withdrawn
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Mar 19, 2019

NSCLC, Metastatic NSCLC, Radiotherapy Trial (Radiotherapy, Thymalfasin)

Withdrawn
  • Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Mar 23, 2019

Metastatic Pancreatic Cancer Trial in Bern, Basel, Zürich (Nivolumab)

Recruiting
  • Metastatic Pancreatic Cancer
  • Bern, BE, Switzerland
  • +2 more
Nov 15, 2022

Small Cell Lung Cancer Recurrent Trial in Goyang-si (Atezolizumab)

Recruiting
  • Small Cell Lung Cancer Recurrent
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Cancer Trial in Wiener Neustadt (Particle radiotherapy, Magnetic resonance imaging, Computertomography)

Recruiting
  • Cancer
  • Particle radiotherapy
  • +5 more
  • Wiener Neustadt, Niederösterreich, Austria
    EBG MedAustron GmbH
Dec 1, 2022

Metastatic Malignant Solid Tumor Trial in Duarte (Biospecimen Collection, Computed Tomography, Stereotactic Body Radiation

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Biospecimen Collection
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Feb 15, 2023

Radiation Effects on Bone

Enrolling by invitation
  • Soft Tissue Sarcoma Adult
  • Control Group
  • +3 more
  • Syracuse, New York
    SUNY Upstate Medical University
Oct 31, 2022

Radiotherapy, Immunology Trial in Ghent (Cyclophosphamide, Stereotactic body radiotherapy)

Withdrawn
  • Radiotherapy
  • Immunology
  • Ghent, Belgium
    University Hospital - Radiotherapy Department
Jul 7, 2021

NSCLC, NSCLC Trial in Switzerland (Durvalumab, Radiotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • NSCLC
  • Aarau, Switzerland
  • +12 more
Oct 17, 2022

Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • IRE plus checkpoint inhibitor
  • IRE plus Checkpoint Inhibitor plus CpG-ODN
  • (no location specified)
Sep 13, 2023

Pancreas Cancer Trial (Nivolumab, Irreversible electroporation (IRE))

Not yet recruiting
  • Pancreas Cancer
  • (no location specified)
Jun 27, 2022

Metastatic Colorectal Cancer Trial in Køge (Irreversible electroporation, Calcium electroporation, Pembrolizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Irreversible electroporation
  • +2 more
  • Køge, Denmark
    Zealand University Hospital
Jan 27, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 2, 2022

Metastatic Nonsmall Cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Stereotactic Body Radiotherapy)

Active, not recruiting
  • Metastatic Nonsmall Cell Lung Cancer
  • Non Small Cell Lung Cancer
  • Stereotactic Body Radiotherapy
  • Philadelphia, Pennsylvania
    Philadelphia CyberKnife
Mar 15, 2022